- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Mental Health Disorders
- Anxiety Disorders
- Bipolar Disorder
- Eating Disorders
- Personality Disorders
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Payer & Financing Models
- Quality Standards & Performance Measures
- Suicide Awareness
- Learning Tracks
- Shareable/Downloadable Content
- Monthly Spotlight
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Supporting Organizations
PsychU webinars offer a platform for experts in the field of mental health to share their knowledge and experiences through live presentations and answer questions from the audience. After the live event, all webinars are available on-demand for PsychU community members to watch (or re-watch) and download the slide deck presentation.
Sleep disturbance is a predominant symptom associated with depression, impacting ~75% of those diagnosed with depression. Insomnia, hypersomnia, and obstructive sleep apnea are all highly prevalent among those with depression.1 An estimated 40% of individuals among the general and healthcare populations have reported sleep problems because of the COVID pandemic,...
Impact of Adherence on Patients with BP I DisorderWebinar March 31, 2022 12:00pm to 1:00pm EDTTreatment non-adherence is a dilemma in bipolar disorder and is one of the leading challenges in providing effective treatments for people diagnosed with BP I disorder. During our discussion today, Dr. Sajatovic and Dr. Goldberg will discuss and define some of these challenges and provide the latest information on treatment-related...
The Depression Dance: Navigating Unresolved Symptoms & Other Treatment ComplexitiesWebinar April 27, 2022 12:00pm to 1:00pm EDTResidual symptoms of depression are very common in patients who are classified as being in response or even remission. In individuals with residual symptoms, we see an increased risk of functional & interpersonal impairments, as well as a significantly increased risk for recurrence of depression. For many patients, residual symptoms...
Re-Imagining The Dopamine Hypothesis Of Schizophrenia: How Can We Find A Balance?Webinar May 24, 2022 12:00pm to 1:00pm EDTThe dopamine hypothesis of schizophrenia has been foundational in elucidating the benefit of dopamine-blocking actions of antipsychotic medications over the past 60 years. Although blocking the D2 receptors may lead to positive symptom-alleviation in schizophrenia, doing so may come at a great cost to the overall well-being of individuals with...
What’s New, Going Away, & Here To Stay: A Look Forward From The OPEN MINDS & Otsuka National Payer SurveyWebinar May 31, 2022 12:00pm to 1:00pm EDTIn 2021, Otsuka America Pharmaceutical, Inc. (OAPI) released The Third Edition Of Trends In Behavioral Health: A Reference Guide On The US Behavioral Health Financing & Delivery System (The Guide). This release focused on the OPEN MINDS survey results that came from interviews of 1,132 health plans. Top payer executives...
Recognizing The Inner Voice: Breaking The LGBTQIA+ Conversation BarrierWebinar June 01, 2022 12:00pm to 1:00pm EDTThe month of June is Pride Month and throughout the world the LGBTQIA+ communities come together to celebrate sexual and gender diversity, and to raise awareness of the ongoing pursuit for equality. NephU and PsychU will be joining the community awareness efforts. During this webinar, our speakers begin by sharing...
Managing Partial Response: Augmentation Strategies In MDDWebinar June 27, 2022 12:00pm to 1:00pm EDTPersistent residual symptoms (e.g., sleep disturbances, cognitive symptoms) have known interference on quality of life and functioning of individuals with major depressive disorder (MDD) who respond to or remit from antidepressant treatment.1 Understanding the inherent challenges in symptom recognition and subsequent treatment, clinicians are tasked with finding optimal symptom relief...
The Effects Of Racism On The Mental Healthcare Community: How Marginalized Patients & Providers Are ImpactedWebinar July 21, 2022 12:00pm to 1:00pm EDTAs a community, we know that the effects of racism are not confined to patients alone--but can impact mental health professionals. This webinar will highlight some of the barriers that healthcare professionals experience, including Black, Indigenous, People of Color (BIPOC) and other marginalized groups. Our presenters will also discuss the...
Digital Health Tools: Combating Stigma & Healthcare DisparitiesWebinar July 28, 2022 12:00pm to 1:00pm EDTDr. Velligan and Dr. Pederson will share their expertise in the areas of digital tools, stigma, and healthcare disparities. Together, they will provide an overview of stigma and healthcare disparities in mental health treatment, and then discuss digital tools used in the treatment of mental illness. Finally, we will explore...
A Conversation With An Expert In Agitation In Alzheimer’s Dementia, A Person With Lived Experience, & A Care PartnerWebinar August 02, 2022 12:00pm to 1:00pm EDTAlzheimer’s dementia is highly prevalent, under-diagnosed, and predicted to increase significantly in the coming decades due to an aging population. Unfortunately, a large proportion of individuals with Alzheimer’s disease (AD) also experience neuropsychiatric symptoms, such as agitation, depression, apathy, and hallucinations. In this webinar, our panelist will be reviewing the...
Panel Discussion On The Role Of Psychotherapy, Cognitive Training, & Digital Platforms For Treatment Of Major Depressive DisorderWebinar August 30, 2022 12:00pm to 1:00pm EDTPsychotherapy, particularly cognitive behavioral therapy, is a widely accepted and effective treatment approach for major depressive disorder.1 Cognitive training represents a promising and novel therapeutic intervention to address cognitive and affective symptoms of depression.2 Individual and systematic barriers may limit initiation and adherence to psychological interventions.3 Digital platforms may be...
988: What’s The Scoop? A Discussion With Experts In Suicide Prevention & Mental HealthWebinar September 13, 2022 12:00pm to 1:00pm EDT988, the three-digit dialing code developed and designed as a suicide and crisis lifeline, went live on July 16, 2022. Since Congress designated 988 in 2020, there has been a lot of excitement, confusion, and buzz around exactly what this new number means for individuals in crisis, healthcare providers, and...
Defining, Evaluating, & Implementing Digital Health ToolsWebinar September 21, 2022 12:00pm to 1:00pm EDTIn this webinar, Dr. Vasan and Dr. Behrens will share their expertise in the areas of digital tools. Together, they will provide definitions of digital health tools and discuss how those tools may help address some unmet needs. They will also provide best practices for digital tool design and clinical...
Quality Matters: An Update From NCQA On Behavioral Health Measurement TrendsWebinar September 27, 2022 12:00pm to 1:00pm EDTThe National Committee for Quality Assurance (NCQA) collects information on the performance of health care service delivery from health plans covering more than 191 million people using its proprietary Healthcare Effectiveness Data and Information Set, or HEDIS. One of health care’s most widely used performance improvement tools, HEDIS consists of...
Pathophysiology Of Agitation Associated With Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter SystemsWebinar October 26, 2022 12:00pm to 1:00pm EDTTau pathology and neurodegeneration in key prefrontal and subcortical brain regions may increase the risk of developing agitation in Alzheimer’s dementia.1 Specifically, agitation in Alzheimer’s dementia may reflect an imbalance between top-down executive control (i.e., hypoactivity in prefrontal regions) and bottom-up emotional drive (i.e., hyperactivity in subcortical regions including the...
Early Intervention in Bipolar DisorderWebinar November 02, 2022 12:00pm to 1:00pm EDTDuring this webinar, Dr. Goldberg and Dr. Tohen will discuss the importance of early intervention in patients diagnosed with bipolar disorder. Together they will share their clinical experience and discuss the implications of early versus delayed intervention and identify and explore potential treatment options in bipolar disorder. Objectives: Describe the...
Schizophrenia Treatment Goals & Shared Decision Making: A Practice-Based Learning WebinarWebinar November 09, 2022 12:00pm to 1:00pm ESTJoin Dr. Correll and Dr. Schooler for a discussion on how to engage patients in their own treatment decisions, help them define their treatment goals, and address treatment barriers that are often associated with schizophrenia. Together, they will lead an engaging practice-based learning session designed to both teach shared decision-making...
Professional Mental Wellness: The Role Of Organizational & Occupational HealthWebinar November 15, 2022 12:00pm to 1:00pm ESTOrganizational and occupational health refers to any workplace health promotion activity or organizational policy designed to support healthy behavior in the workplace and to improve health outcomes.1 Usually, this includes physical health programs such as smoking cessation, health screenings, exercise initiatives, and vaccination clinics; however, many organizations have also been...
The Unicorns Of Behavioral Health: Who They Are & How They Impact Patient CareWebinar December 01, 2022 12:00pm to 1:00pm ESTBy July 2021, investments in digital health exceeded all of 2020. Just in the U.S. $29.1 billion was funneled into digital health startups. Among the top funded digital health clinical domains mental health took the lead at $5.1 billion on its own. This is over 10 times the amount it...
The Value Of Digital TherapeuticsWebinar December 06, 2022 12:00pm to 1:00pm ESTDescription: Digital therapeutics, a subset of digital health, are evidence-based, clinically validated software that combine health and technology to prevent, treat, or manage a medical condition. In this discussion, Dr. Madhukar Trivedi and Dr. Albert Mei will introduce the role of digital therapeutics in the current mental health landscape, describe...
Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of SchizophreniaWebinar December 13, 2022 12:00pm to 1:00pm ESTTrace amines and trace amine-associated receptors (TAAR) are found throughout the brain and peripheral tissues and have modulating effects on neurotransmitters including dopamine, glutamate, and serotonin.1,2 The speaker(s) will discuss what are some of the potential effects of TAAR1 on neurotransmitter signaling related to schizophrenia and some of the preclinical...
Burden & Treatment Considerations For Agitation Associated With Alzheimer’s DementiaWebinar January 11, 2023 12:00pm to 1:00pm ESTAgitation associated with Alzheimer’s Dementia (AAD) lead to worsening outcomes in an already devastating disease. A patient-centered focus is recommended for a comprehensive treatment plan. In this webinar, the speakers will review the burden of AAD, then discuss current treatment recommendations and unmet needs. Objectives: Review the economic and caregiver...
Pharmacokinetics, Plasma Concentrations & (Their) Clinical RelevanceWebinar January 26, 2023 12:00pm to 1:00pm ESTPharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors, ultimately impacting treatment of mental health. In this webinar, we will first provide an overview of pharmacokinetics and pharmacodynamics. Then,...
Addressing Unresolved Symptoms of Major Depressive Disorder (MDD): The Importance of Norepinephrine, Serotonin, & Dopamine ModulationWebinar February 16, 2023 12:00pm to 1:00pm ESTJoin the PsychU community for this exciting webinar featuring experts in psychiatry, Joseph Goldberg and Vladimir Maletic, as they describe aspects of pathophysiology in major depressive disorder. An emphasis will be placed on the role of several monoamine neurotransmitter systems including norepinephrine, serotonin, and dopamine. Drs. Goldberg and Maletic will...
- Addressing Unresolved Symptoms Of Major Depressive Disorder (MDD): The Importance Of Norepinephrine, Serotonin, & Dopamine Modulation
- Pharmacokinetics, Plasma Concentrations (Their) & Clinical Relevance
- Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia
- Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target for the Treatment of Schizophrenia
Join the PsychU community for this exciting webinar featuring experts in psychiatry, Joseph Goldberg and Vladimir Maletic, as they describe aspects of pathophysiology in major depressive disorder. An emphasis will…
REQUEST A PRESENTATION
Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.
Top Requested Presentations
The Neuropsychiatric Inventory: Development & Applications
Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR
Distinguishing Sedation From Efficacy In Antipsychotic Treatment
Not sure where to start on the thousands of resources in the PsychU library? PsychU has created learning tracks to give community members a resource guide! Pick a learning track, review the materials outlined, and complete the Test Your Knowledge questions to participate in a resource ‘crash-course’ on one of the topics listed below.
- PsychU For You
- Mental Health Disorders
- Topics of Interest
- Supporting Organizations